Guidelines on MBC*

EUROPA DONNA recommends that advocates become knowledgeable about evidence-based guidelines and learn about current best practices.  In this way we can advocate for appropriate services and methods of support for MBC patients.  Below is a list of some recent MBC guidelines:


International Consensus Conference for Advanced Breast Cancer:

The International Consensus Conference for Advanced Breast Cancer is a major international breast cancer conference held biennially in Lisbon, Portugal.  Its primary aim is the development of international consensus guidelines for the management of ABC patients.  Representatives of breast cancer patient advocacy groups are invited to participate in the conference and to actively contribute to the scientific programme and the consensus session. The ABC guidelines are jointly developed by ESO (European School of Oncology) and ESMO (European Society of Medical Oncology). EUROPA DONNA members serve on the consensus panel as well as the Breast Cancer Patient Advocacy Committee. The conference is held every two years.

The Advanced Breast Cancer 5th ESO-ESMO Consensus Conference (ABC 5) took take place in Lisbon, Portugal on 14-16 November 2019.

To see presentations from the conference click here.


Consensus Documents:



The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer; its mission is to conquer cancer through research, education, and promotion of the highest quality patient care.  ASCO develops and publishes clinical practice guidelines, provisional clinical opinions, and guideline endorsements, providing evidence-based recommendations to serve as a guide for doctors and outline appropriate methods of treatment and care. The following are links to several ASCO guidelines publications on Metastatic Breast Cancer:

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
May 23, 2016

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: : American Society of Clinical Oncology Guideline
July 20, 2015

Chemotherapy and Targeted Therapy for Women with Human Epidermal Growth Factor Receptor 2-Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Guideline
September 2, 2014

American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer Update
March 20, 2011



*Please note: EUROPA DONNA is Europe’s breast cancer advocacy organization and does not make treatment recommendations or endorse any specific treatment modalities.  Treatment options should always be discussed with your health care provider.